Risk Factors for Hydroxychloroquine and Chloroquine Retinopathy
Author:
Browning David J.
Publisher
Springer New York
Reference126 articles.
1. Browning DJ. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity. Am J Ophthalmol. 2002;133:649–56.
2. Mackenzie AH. Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials. Am J Med. 1983;75:40–5.
3. Lee AG. Hydroxychloroquine screening. Who needs it, when, how, and why? Br J Ophthalmol. 2005;89:521–2.
4. Marmor MF, Kellner U, Lai TYY, Lyons JS, Mieler WF. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology. 2011;118:415–22.
5. Albert DA, Debois LKL, Lu KF. Antimalarial ocular toxicity, a critical appraisal. J Clin Rheumatol. 1998;4:57–62.